V-Co Investors 3 LLC - 31 Mar 2026 SCHEDULE 13D Report for Vivos Therapeutics, Inc. Common Stock, par value $0.0001 per share (VVOS)

Filing Manager: V-Co Investors 3 LLC
Reporting Manager: Michael C. Skaff
Security: Vivos Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: VVOS
Shares outstanding: 13,548,357 shares
Disclosed Ownership: 2,696,123 shares
Ownership: 20%
Form type: SCHEDULE 13D
Filing time: 02 Apr 2026, 18:32:59 UTC
Date of event: 31 Mar 2026
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title	CIK
V-CO Investors LLC	3.8%	514,498	514,498	Michael C. Skaff	Michael C. Skaff, Managing Director of SP Manager LLC, its Manager	0002049575
V-Co Investors 2 LLC	6.1%	828,000	828,000	Michael C. Skaff	Michael C. Skaff, Managing Director of SP Manager LLC, its Manager	0002114466
V-Co Investors 3 LLC	10%	1,353,625	1,353,625	Michael C. Skaff	Michael C. Skaff, Managing Director of SP Manager LLC, its Manager	0002114460
SP Manager LLC	20%	2,696,123	2,696,123	Michael C. Skaff*	Michael C. Skaff, Managing Director
Michael C. Skaff	20%	2,696,123	2,696,123	Michael C. Skaff*	Michael C. Skaff, Managing Director	0002074003